# Sources — Ada Lovelace

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 6, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. McCarthy L. "About Ada Lovelace." Bodleian Libraries, University of Oxford (Ada Lovelace blog). "Born Augusta Ada Byron on 10 December 1815" to Lord Byron and Anne Isabella Byron; "On 8 July 1835 she married William King, 8th Baron King"; between 1842 and 1843 she translated an article on Babbage's engine and added "an elaborate set of notes of her own, simply called Notes"; "Ada's health was always fragile, but it declined dramatically after 1843"; she died at 36, the age at which her father had died, "on 27 November 1852, from uterine cancer," and was buried "at her request, next to her father." https://blogs.bodleian.ox.ac.uk/adalovelace/about-ada-lovelace/
2. O'Connor JJ, Robertson EF. "Augusta Ada King, Countess of Lovelace." MacTutor History of Mathematics, University of St Andrews. Born in Piccadilly; in 1829 she "contracted measles from which she took a long while to recover"; married William King on July 8, 1835, who "was created an Earl in 1838"; the Notes on Menabrea's memoir published in 1843 in Taylor's *Scientific Memoirs* under the initials AAL, often considered "the first ever computer program," including the Bernoulli numbers; by the end of 1843 "she was taking several medicines for different health problems"; in 1844 a recent illness left her "utterly unable to think even of my studies"; she considered writing "a scientific study of the effects of opium and wine" from her own experience; "Gambling on horses was another passion in these years and she pawned some of her jewels to finance it"; by January 1852 she "was wracked with pain"; "She owed £2000 in gambling debts when she died"; died in Marylebone. https://mathshistory.st-andrews.ac.uk/Biographies/Lovelace/
3. Zielinski S. "Who Was Ada Lovelace?" *Smithsonian Magazine*, March 24, 2010. "She was often ill and became bedridden for an entire year after a bout with the measles"; "she began having what she called heart or rheumatic attacks in the 1840s"; "By 1851 she was extremely sick with uterine cancer, from which she died at the age of 36 on November 27, 1852." https://www.smithsonianmag.com/science-nature/who-was-ada-lovelace-25830687/
4. Biography.com Editors. "Ada Lovelace Biography" (last updated May 6, 2021). "Lovelace's health suffered, however, after a bout of cholera in 1837"; "lingering problems with asthma and her digestive system"; "Doctors gave her painkillers, such as laudanum and opium, and her personality began to change"; "mood swings and hallucinations"; buried "in the graveyard of the Church of St. Mary Magdalene in Hucknall." General biography; claims resting on it alone are graded probable. https://www.biography.com/scientist/ada-lovelace
5. Warr T. Review of Miranda Seymour, *In Byron's Wake* (2018). *Historical Novels Review* 85, August 2018. "As Ada lay dying in her thirties from uterine cancer, it was revealed that she led a ruinous horse-betting ring," "had borrowed money from shady people and had pawned her diamonds twice." https://historicalnovelsociety.org/?p=22040
6. Computer History Museum. "Augusta Ada King (née Byron), Countess of Lovelace" (Revolution exhibit, portrait courtesy of the Science Museum). She died of cancer at 36. https://www.computerhistory.org/revolution/calculators/1/51/207
7. Mathematical Institute, University of Oxford. "Exploding the myths of Ada Lovelace's mathematics." Her 1843 paper; her mathematical ambition "sadly curtailed by her ill-health and early death." https://www.maths.ox.ac.uk/node/25695
8. HISTMED Master Roster v3. Internal project source (row NI031, added for batch 15). Its clinical claims were provisional and were not treated as independent corroboration.

## Clinical guidance

1. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer. Staging with pelvic MRI and PET-CT; biopsy of suspected metastases when feasible; for metastatic disease with PD-L1 combined positive score 1 or more, platinum, paclitaxel and pembrolizumab with or without bevacizumab as preferred first-line therapy; tumor PD-L1, mismatch repair or MSI, and HER2 testing; palliative radiation for bleeding. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1426
2. Bhatla N, et al. "Revised FIGO staging for carcinoma of the cervix uteri." *Int J Gynaecol Obstet* 2019;145:129–135. PMID 30656645. Stage IVB: spread to distant organs; imaging and pathology may be used. https://pubmed.ncbi.nlm.nih.gov/30656645/
3. Colombo N, et al. "Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer" (KEYNOTE-826). *N Engl J Med* 2021;385:1856–1867. PMID 34534429. Pembrolizumab 200 mg every 3 weeks with platinum-based chemotherapy, with or without bevacizumab; longer progression-free and overall survival with a PD-L1 combined positive score of 1 or more. https://pubmed.ncbi.nlm.nih.gov/34534429/
4. Sanders JJ, et al. "Palliative Care for Patients With Cancer: ASCO Guideline Update." *J Clin Oncol* 2024;42:2336–2357. PMID 38748941. Interdisciplinary palliative care beginning early in the course of the disease, alongside active treatment. https://pubmed.ncbi.nlm.nih.gov/38748941/
5. Paice JA, et al. "Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline." *J Clin Oncol* 2023;41:914–930. PMID 36469839. Opioids for moderate-to-severe cancer pain; start at the lowest dose with early assessment and frequent titration; monitor and prevent adverse effects. https://pubmed.ncbi.nlm.nih.gov/36469839/
6. Dowell D, et al. "CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022." *MMWR Recomm Rep* 2022;71(RR-3):1–95. PMID 36327391. Its abstract excludes pain related to cancer and patients receiving palliative care; it is cited for its general safe-prescribing practices (naloxone, prescription drug monitoring, tapering). https://pubmed.ncbi.nlm.nih.gov/36327391/
7. Gilligan T, et al. "Patient-Clinician Communication: ASCO Guideline Update." *J Clin Oncol* 2026;44:1040–1057. PMID 41805420. https://pubmed.ncbi.nlm.nih.gov/41805420/
8. Hwang JP, et al. "Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update." *J Clin Oncol* 2020;38:3698–3715. PMID 32716741. https://pubmed.ncbi.nlm.nih.gov/32716741/
9. Schneider BJ, et al. "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update." *J Clin Oncol* 2021;39:4073–4126. PMID 34724392. Thyroid tests at baseline and every 4 to 6 weeks; continue immunotherapy for asymptomatic or mild thyroid dysfunction. https://pubmed.ncbi.nlm.nih.gov/34724392/
10. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), anemia monograph: ferritin 6 to 8 weeks after intravenous iron; target ferritin at least 30 ng/mL; restrictive transfusion threshold of 7 to 8 g/dL. https://patrickrutledge.github.io/topthirty/
11. Preventive visit: Medicare Preventive Services reference (Aether Forge, 2026); USPSTF A and B recommendations, depression (2023), unhealthy alcohol use (2018), intimate partner violence (2018), HIV (2019) and hepatitis C (2020) screening; CDC adult immunization schedule by medical condition, https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html; universal adult hepatitis B vaccination (MMWR 2022;71(13):477–483, PMID 35358162).

## Editorial resolutions

- **Index age and dates.** The modern episode presents her at 35. The synthetic date of birth is December 10, 1990 (the true month and day), so the shift is 175 years. The index visit on June 2, 2026 maps to June 2, 1851, and the last visit on October 20, 2026 to October 20, 1851: within 1851, when the Smithsonian says she was extremely sick with uterine cancer, and before January 1852, when MacTutor says she was wracked with pain. Her day-to-day whereabouts in 1851 were not verified; the record places her in London, where she died.
- **Name.** The display name is "Ada Lovelace"; the aliases "Augusta Ada King" and "Augusta Ada Byron" appear in no other record. "Lovelace" comes from her husband's earldom rather than a family surname, but "Ada Lovelace" is the name by which she is known and it splits into a given name and a final name, so identity.name_parts is not used.
- **Other people named.** Charles Babbage, Luigi Menabrea, Lord Byron and Anne Isabella Byron appear only in documented claims; none has a record in the dataset, so identity.historical_mentions is not needed. The modern episode does not name or attribute any statement, decision or health fact to her husband, mother, children or anyone else; the household is described without names.
- **Childhood illness (correction to the brief).** The brief describes measles at 13 to 14 that left her unable to walk. MacTutor gives measles in 1829 with a long recovery and the Smithsonian says she was bedridden for a year; paralysis, inability to walk and crutches were not found in a fetched source, so the claim says only what the sources say.
- **Opium, laudanum and cannabis.** Laudanum and opium as painkillers given by her doctors rest on a general biography (Biography.com) and are graded probable; her own thought of writing on the effects of opium and wine (MacTutor) supports her use of opium. Both claims are marked sensitive. Cannabis was not found in a fetched source and is left out. No substance use disorder is inferred historically, and none is diagnosed in the modern episode.
- **Final illness (corrections to the brief).** Uterine cancer is documented by the Bodleian, the Smithsonian and the Seymour review. The brief's heavy bleeding, bloodletting and opiates in the final illness were not found in a fetched source: bloodletting is left out; the opiates of her final months are not stated beyond the general laudanum and opium claim; and MacTutor's "wracked with pain" in January 1852 is recorded as a later event. The Bodleian's archive catalogue lists an account of her illness by her physician (1852), but the catalogue page could not be fetched, so it is not cited. Some popular accounts call the cancer cervical; no fetched source said so.
- **Choice of cervical rather than endometrial cancer.** Nineteenth-century "cancer of the womb" did not distinguish the cervix from the body of the uterus. At 35, with bleeding after intercourse and between periods and a foul discharge, cervical cancer is far more likely than endometrial cancer, and the cervical cancer of a woman never screened is the more common modern pattern. The modern episode therefore uses an HPV 18 positive adenocarcinoma of the endocervix. This is a synthetic choice, not a retrospective diagnosis (no R claim is made).
- **How this record differs from the other gynecologic cancer records.** The existing cervical cancer record (HR-ML025) teaches curative chemoradiation for locally advanced squamous cervical cancer; the existing endometrial cancer record (HR-ML032) teaches the evaluation and molecular classification of endometrial cancer. This record teaches metastatic (stage IVB) disease treated with palliative intent from diagnosis: confirming distant spread by biopsy, hemostatic pelvic radiation, chemotherapy with pembrolizumab under KEYNOTE-826 without bevacizumab while bleeding, early specialist palliative care, conversion of a long-term opium tincture to measured morphine and later a taper, immune-related thyroid monitoring, and goals-of-care conversations.
- **Genetic testing.** Germline testing is not indicated for cervical cancer, which is caused by HPV and is not part of a hereditary cancer syndrome; tumor PD-L1, mismatch repair and HER2 are tested for treatment choice.
- **Opioid guidance.** The CDC 2022 guideline does not apply to cancer pain or palliative care; the opioid plan follows the ASCO 2023 cancer-pain guideline and borrows the CDC's general safety practices. The starting conversion (opium tincture 0.5 mL, about 5 mg morphine, four to six times a day, about 20 to 30 mg a day) to measured morphine solution 5 mg as needed, then long-acting morphine 15 mg twice a day, is a clinical judgment.
- **Gambling and debts.** Her gambling on horses, the pawned jewels and the debts are documented and marked sensitive. The modern social history (betting, borrowed money, a positive brief gambling screen, and debt advice) is synthetic and anchored to them; no gambling disorder is diagnosed.
- **Mood.** The synthetic PHQ-9 scores (8, 9, 7, 5) and PHQ-2 (2) are below the thresholds, no behavioral-health diagnosis is made, and no safety assessment is required. Psycho-oncology counseling is offered at the six-week visit.
- **Sick and preventive visits.** A periodic adult preventive visit (age 35) on August 18, 2026 (true frame August 18, 1851) and a same-day sick visit on July 7, 2026 (true frame July 7, 1851) were added. The sick visit is drug-induced constipation from long-acting morphine and ondansetron a week after the first chemotherapy cycle, chosen because it follows from the record's own medicines and teaches the exclusion of bowel obstruction; it does not echo a documented illness. The preventive visit vaccinates an adult on chemotherapy and immunotherapy (inactivated vaccines only) and records advance care planning.
- **Focused visits.** The four chronic-care follow-ups (two, six, fourteen and twenty weeks) are documented as focused visits on the NCCN cervical cancer guideline and KEYNOTE-826 (blood counts, kidney and liver tests, neuropathy, restaging), the ASCO immune-related adverse events guideline (thyroid tests every six weeks), the ASCO opioid guideline (pain, sedation, bowels, naloxone, storage, prescription monitoring, opioid use disorder, taper), the ASCO palliative care and communication guidelines, and the CMID anemia monograph. The CMID does not cover cervical cancer. Two protocol deviations are recorded at the fourteen-week visit: the six-week TSH and free T4 on pembrolizumab, and the ferritin due 6 to 8 weeks after intravenous iron, were both missed and drawn at twelve weeks, with normal or reassuring results, no harm, and corrective actions. The TSH of 7.8 with a normal free T4 at the last visit is a synthetic, mild immune-related thyroid finding, not a new problem.
- **Consultation.** The gynecologic oncology consultation by the fictional Dr. Lindgren-Osei on the second visit is synthetic. Its recommendations (lung biopsy, palliative pelvic radiation, carboplatin, paclitaxel and pembrolizumab without bevacizumab, biomarker testing without germline testing, long-acting morphine, early palliative care, and iron) are those the later visits carry out.
- **Goals of care.** The decision at the fourteen-week visit not to attempt resuscitation, while continuing all other treatment, is synthetic and makes no prediction about her death.
- Lovelace died in 1852, so the recent-death review rule does not apply. Ordinary clinical and provenance reviews remain required.
